Mumps virus strain B level jeryl lynn live antigen Completed Phase 4 Trials for Measles / Rubella / Adverse Event Following Immunization / Mumps Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT03160820Study on Immunization Schedule of Beijing Tiantan Biological's Measles-mumps-rubella(MMR) Vaccine